Injective's price reached $5.51, representing an 18% increase over the past 24 hours and a 43% gain from one week ago. The rally marks a significant recovery for the Layer 1 blockchain platform, which has been building institutional-grade infrastructure over recent weeks. Injective price surged 11.88% to $4.84 on May 12 as a single announcement repositioned INJ at the center of Cosmos stablecoin infrastructure, with volume hitting $163 million, up 122%. Injective USDC is now the default denomination across Cosmos Hub and dYdX, enabling one-signature cross-chain transfers, sub-second finality, and near-zero gas costs with CCTP support. The integration is locked for a minimum of four years, with a portion of fees generated by Injective USDC routed to programmatic ATOM buybacks.